These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35378276)

  • 1. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
    Zhang W; Yan Y; Wu Y; Yang H; Zhu P; Yan F; Zhao R; Tian P; Wang T; Fan Q; Su Z
    Pharmacol Res; 2022 May; 179():106204. PubMed ID: 35378276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
    Slee A; Nazareth I; Bondaronek P; Liu Y; Cheng Z; Freemantle N
    Lancet; 2019 Feb; 393(10173):768-777. PubMed ID: 30712879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis.
    Ma Y; Nie X; Zhu G; Qi W; Hao L; Guo X
    CNS Drugs; 2024 Feb; 38(2):93-104. PubMed ID: 38300476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
    Sarris J; McIntyre E; Camfield DA
    CNS Drugs; 2013 Apr; 27(4):301-19. PubMed ID: 23653088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis.
    He H; Xiang Y; Gao F; Bai L; Gao F; Fan Y; Lyu J; Ma X
    J Psychiatr Res; 2019 Nov; 118():21-30. PubMed ID: 31473564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential oils for treating anxiety: a systematic review of randomized controlled trials and network meta-analysis.
    Tan L; Liao FF; Long LZ; Ma XC; Peng YX; Lu JM; Qu H; Fu CG
    Front Public Health; 2023; 11():1144404. PubMed ID: 37325306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
    Möller HJ; Volz HP; Dienel A; Schläfke S; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):183-193. PubMed ID: 29150713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.
    Yeung KS; Hernandez M; Mao JJ; Haviland I; Gubili J
    Phytother Res; 2018 May; 32(5):865-891. PubMed ID: 29464801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
    Dold M; Bartova L; Volz HP; Seifritz E; Möller HJ; Schläfke S; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1615-1628. PubMed ID: 36717399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
    Zhao J; Ai J; Mo C; Shi W; Meng L
    Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and acceptability of treatments for depressive symptoms in cognitive impairment: A systematic review and Bayesian network meta-analysis.
    Jin B; Xv Y; Zhang B; Qiao L; Liu H
    Front Aging Neurosci; 2022; 14():1037414. PubMed ID: 36578447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH; Ernst E
    J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatments for adults with post-traumatic stress disorder: A network meta-analysis of comparative efficacy and acceptability.
    de Moraes Costa G; Zanatta FB; Ziegelmann PK; Soares Barros AJ; Mello CF
    J Psychiatr Res; 2020 Nov; 130():412-420. PubMed ID: 32891916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    Jin B; Liu H
    J Neurol; 2019 Oct; 266(10):2363-2375. PubMed ID: 30666436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
    Bartova L; Dold M; Volz HP; Seifritz E; Möller HJ; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):51-63. PubMed ID: 35262795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
    Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.